Who Paid My Doc
Melissa Fischer
Urogynecology and Reconstructive Pelvic Surgery Royal Oak, MI Medical Doctor
NPI 1326067067 CMS profile 150422
3535 W 13 Mile Rd Ste 404, Royal Oak, MI 48073
General payments
$10,739
Research payments
$2,100
Ownership & investment interest
$0
Research they led as principal investigator
$133,068
Through program year 2025, Melissa Fischer of Royal Oak, MI is reported in the CMS Open Payments database as having received $10,739 across 216 general payments and $2,100 in research payments paid to them. Separately, studies naming them as principal investigator received $133,068 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 65th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,705 | 48 | |
| 2024 | General | $882 | 22 | |
| 2023 | General | $1,227 | 32 | |
| 2022 | General | $1,118 | 31 | |
| 2022 | Research | $2,100 | 1 | |
| 2021 | General | $1,021 | 31 | |
| 2020 | General | $413 | 8 | |
| 2019 | General | $3,373 | 44 |
Beside peers
- Melissa Fischer
- Urogynecology and Reconstructive Pelvic Surgery median
- Middle half of Urogynecology and Reconstructive Pelvic Surgery
- National median
In program year 2025, general payments to Melissa Fischer were reported at $2,705. Among 149 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $779 and the middle half received between $301 and $2,705.
Show as a table
| Year | Melissa Fischer | Urogynecology and Reconstructive Pelvic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,373 | $799 | $319–$2,013 | $163 |
| 2020 | $413 | $384 | $158–$1,360 | $114 |
| 2021 | $1,021 | $641 | $247–$2,515 | $132 |
| 2022 | $1,118 | $843 | $347–$2,794 | $149 |
| 2023 | $1,227 | $819 | $308–$2,302 | $160 |
| 2024 | $882 | $882 | $306–$2,459 | $164 |
| 2025 | $2,705 | $779 | $301–$2,705 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 27 drugsPart D claims
4,071
Drug cost
$847,449
Branded share of claims
47%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | Brand | 582 | $563,195 | |
| Mirabegron Er Mirabegron | Brand | 207 | $118,249 | |
| Methenamine Hippurate | Generic | 459 | $35,965 | |
| Solifenacin Succinate | Generic | 490 | $21,995 | |
| Fosfomycin Tromethamine | Generic | 77 | $21,017 | |
| Tolterodine Tartrate Er Tolterodine Tartrate | Brand | 184 | $18,863 | |
| Trospium Chloride | Generic | 251 | $17,854 | |
| Trospium Chloride Er Trospium Chloride | Brand | 44 | $9,019 | |
| Premarin Estrogens, Conjugated | Brand | 16 | $8,936 | |
| Estradiol | Generic | 116 | $6,974 |
The 10 drugs with the highest cost, of 27 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 118 billing codesPaid by Medicare
$309,889
Medicare patients
1,323
Services billed
7,280
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 59% | |
| Ischemic heart disease | 34% | |
| Diabetes | 31% | |
| Chronic kidney disease | 30% | |
| Depression | 27% | |
| Osteoporosis | 25% | |
| Cancer | 23% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
First 5 of 7 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| PROVENGE |
|
$131 | — | — |
| LYNPARZA |
|
$50 | — | — |
| KEYTRUDA |
|
$35 | — | — |
| PLUVICTO |
|
$27 | — | — |
| JELMYTO |
|
$22 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 7 in the dashboard with a free accountRecords
217 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Urogynecology and Reconstructive Pelvic Surgery in Michigan
Priyanka Gupta
Urogynecology and Reconstructive Pelvic Surgery · Ann Arbor, MI
Anne Cameron
Urogynecology and Reconstructive Pelvic Surgery · Brighton, MI
Gabrielle Rohrer
Urogynecology and Reconstructive Pelvic Surgery · Royal Oak, MI
Pradeep Nagaraju
Urogynecology and Reconstructive Pelvic Surgery · Royal Oak, MI
Giulia Ippolito
Urogynecology and Reconstructive Pelvic Surgery · Ann Arbor, MI
Samir Hamati
Urogynecology and Reconstructive Pelvic Surgery · Spring Lake, MI
Related records
Urogynecology and Reconstructive Pelvic Surgery in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Urogynecology and Reconstructive Pelvic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.